Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: wrinkled (3), creased (4), ruled (587)

Lymphoma patient-initiated follow-up - patient information

Description: This booklet explains what patient-initiated follow-up (PIFU) for lymphoma is and what it involves so you know what to
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lymphoma-patient-initiated-follow-up-475-PIL.pdf

Lynch syndrome - patient information

Description: This leaflet contains information about Lynch syndrome.
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Lynch-syndrome-1431-PIL.pdf

Cytoreductive surgery for gynaecological cancer - patient information

Description: This factsheet explains what cytoreductive surgery is, what the procedure involves and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Cytoreductive-surgery-for-gynaecological-cancer-3842-PIL.pdf

Selinexor Bortezomib Dexamethasone

Description: Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZOMIB (SC) – DEXAMETHASONE (PO) Indication Selinexor plus bortezomib and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf

Atezolizumab SC-Carboplatin(AUC5)-Etoposide (IV/PO)

Description: Chemotherapy Protocol LUNG CANCER– SMALL CELL (SCLC) ATEZOLIZUMAB-SC-CARBOPLATIN (AUC5)-ETOPOSIDE(IV/PO) Regimen • Lung - AtezolizumabSC-Carboplatin (AUC5)-Etoposide(IV
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Atezolizumab-SC-CarboplatinAUC5-Etoposide-IVPO.pdf

Curves in the spine - patient information

Description: We've written this booklet as a guide to scoliosis and hyperkyphosis, two kinds of curve in the spine.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Curves-in-the-spine-1557-PIL.pdf

AmB - Brexucel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Mantle Cell lymphoma (MCL) AmB – BREXUCEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Ambulatory
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Brexucel-Cyclophosphamide-500-Fludarabine-30-Ver-1.pdf

AmB LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan

Description: Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LEAM-split-Lomustine-Cytarabine-Etoposide-Melphalan.pdf

Patient-initiated follow-up (PIFU) for CLL, SLL, LMZL and HCL - patient information

Description: This booklet contains a summary of patient-initiated follow-up (PIFU) for chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), leukaemic
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Patient-initiated-follow-up-PIFU-for-CLL-SLL-LMZL-and-HCL-3322-PIL.pdf

Endometrial Carboplatin-Cisplatin-PaclitaxelRT(21day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-CISPLATIN-PACLITAXEL RT Regimen • Endometrial-Carboplatin (AUC5)-Cisplatin-Paclitaxel RT Indication • The treatment of endometrial
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/Endometrial-Carboplatin-Cisplatin-Paclitaxel-RT-21day.pdf

331 to 340 of 747

Previous … 32 33 34 35 36 … Next